Your browser doesn't support javascript.
loading
Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?
López-Vilella, Raquel; Paniagua-Martín, María J; González-Vílchez, Francisco; Donoso Trenado, Víctor; Barge-Caballero, Eduardo; Sánchez-Lázaro, Ignacio; Aller Fernández, Ana V; Martínez-Dolz, Luis; Crespo-Leiro, María G; Almenar-Bonet, Luis.
Afiliação
  • López-Vilella R; Heart Failure and Transplantation Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Paniagua-Martín MJ; Department of Cardiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • González-Vílchez F; Department of Cardiology, Complejo Hospitalario Universitario de A Coruña, Servicio Galego de Saúde (SERGAS), A Coruña, Spain.
  • Donoso Trenado V; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Barge-Caballero E; Heart Failure and Transplantation Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Sánchez-Lázaro I; Department of Cardiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Aller Fernández AV; Department of Cardiology, Complejo Hospitalario Universitario de A Coruña, Servicio Galego de Saúde (SERGAS), A Coruña, Spain.
  • Martínez-Dolz L; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
  • Crespo-Leiro MG; Heart Failure and Transplantation Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Almenar-Bonet L; Department of Cardiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Transpl Int ; 35: 10197, 2022.
Article em En | MEDLINE | ID: mdl-35387398
ABSTRACT

Background:

Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. The aim of this study was to analyze the causes of post-transplant TR and its effect on overall mortality.

Methods:

This is a retrospective observational study of all transplants performed in two Spanish centers (1009 patients) between 2000 and 2019. Of the total number of patients, 809 had no TR or mild TR and 200 had moderate or severe TR. The etiology of TR was analyzed in all cases.

Results:

The prevalence of moderate and severe TR was 19.8%. The risk of mortality was greater when TR was caused by early primary graft failure (PGF) or rejection (p < 0.05). TR incidence was related to etiology incidence of PGF-induced TR was higher in the first period, while TR due to rejection and undefined causes occurred more frequently in three periods in the first year, in the 10-14-year period following HTx, and in the long term (16-18 years). In the multivariable analysis, TR was significantly associated with mortality/retransplantation (HR1.04, 95% CI1.01-1.07, p0.02).

Conclusion:

The development of TR after HTx is relatively frequent. The annual incidence depends on TR severity and etiology. The risk of mortality is greater in severe TR due to PGF or rejection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência da Valva Tricúspide / Transplante de Coração Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência da Valva Tricúspide / Transplante de Coração Idioma: En Ano de publicação: 2022 Tipo de documento: Article